S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NASDAQ:SUPN

Supernus Pharmaceuticals SEC Filings & 10K Form

$26.79
+0.34 (+1.29%)
(As of 05/13/2022 04:00 PM ET)
Add
Compare
Today's Range
$26.03
$27.07
50-Day Range
$25.33
$34.25
52-Week Range
$23.15
$34.50
Volume
1.02 million shs
Average Volume
460,370 shs
Market Capitalization
$1.43 billion
P/E Ratio
20.61
Dividend Yield
N/A
Beta
1.12

Supernus Pharmaceuticals (NASDAQ:SUPN) SEC Filings

DateFilerForm TypeView
05/12/2022
4:15 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2022
4:29 PM
Supernus Pharmaceuticals (Filer)
Form NT 10-Q
05/09/2022
4:22 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2022
3:42 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2022
3:18 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2021
4:17 PM
DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2021
4:13 PM
DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2021
11:52 AM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2021
4:28 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2021
3:36 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2021
11:30 AM
Supernus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/25/2021
7:12 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2021
8:04 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
3:35 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2021
3:46 PM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
05/24/2021
3:44 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
3:58 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
1:34 PM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
04/30/2021
1:31 PM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
04/14/2021
7:24 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
5:23 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:30 PM
Supernus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
4:27 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
11:48 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
5:55 PM
Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:54 PM
Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:54 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:53 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:51 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:49 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:49 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:49 PM
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:49 PM
Banyai William (Reporting)
Supernus Pharmaceuticals (Issuer)
Twist Bioscience Corp (Issuer)
Twist Bioscience Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:48 PM
GEMAYEL GEORGES (Reporting)
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:48 PM
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:47 PM
Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:46 PM
NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:46 PM
Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
4:14 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:50 PM
BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
01/04/2021
6:59 PM
Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2020
4:49 PM
Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
7:20 PM
Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
4:27 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
3:19 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
4:43 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
2:31 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2020
5:04 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
11:03 AM
Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
11:00 AM
Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2020
11:26 AM
Supernus Pharmaceuticals (Filer)
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:31 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
4:12 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2020
3:11 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:12 PM
Supernus Pharmaceuticals (Filer)
Form 8-K/A
08/17/2020
3:52 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2020
3:35 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
3:13 PM
Supernus Pharmaceuticals (Filer)
Form NT 10-Q
07/28/2020
3:35 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
2:18 PM
Supernus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/15/2020
4:13 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
7:07 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
3:33 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
5:59 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
1:14 PM
Supernus Pharmaceuticals (Filer)
Form NT 10-Q
05/11/2020
5:42 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
3:52 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
11:00 AM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
8:27 AM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
8:26 AM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
03/23/2020
7:36 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
4:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
02/28/2020
12:05 PM
Supernus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2020
5:51 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:40 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2020
5:33 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:31 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2020
4:59 PM
NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
3:36 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
10:07 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2019
3:02 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
3:12 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
1:59 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
4:14 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:04 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
3:29 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
4:27 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
11:25 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
10:02 AM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:57 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
4:28 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
4:20 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
7:06 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:29 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:18 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
2:38 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
4:30 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
3:12 PM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
04/29/2019
2:43 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:33 PM
Matushansky Igor (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.